Rare diseases
Investigational molecules
Locations
Back to Czechia12 clinical trials in Marianske Lazne, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
CzechiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
CzechiaCzechiaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
CzechiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CzechiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
CzechiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CzechiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
CzechiaStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on preventive cardiology, particularly studying new approaches to reduce the risk of major cardiovascular events in high-risk patients.
Multiple trials evaluating innovative treatments to protect against heart disease complications.
Studies examining combination therapies for heart failure, including investigations of novel drug combinations to improve patient outcomes and reduce hospitalizations.
Research aimed at enhancing current treatment protocols for heart failure patients.
Innovative trials targeting atherosclerotic cardiovascular disease, exploring new therapeutic options for patients with established vascular conditions.
Advanced studies focusing on reducing major adverse cardiovascular events.
Clinical investigations comparing treatment options for atrial fibrillation, with emphasis on safety and efficacy of new therapeutic approaches.
Evaluating novel treatments for irregular heart rhythms and related complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
